Skip to main navigation

Events & Presentations

Presentations

PRESENTATION - SGO 2024 - Phase 1 Analysis From the PYNNACLE Phase 1/2 Study of PC14586 in the Subgroup of Patients With Advanced Ovarian Cancer Harboring a TP53 Y220C Mutation

PRESENTATION - KOL Webinar or Phase 1/2 PYNNACLE study of PC14586 from the 2023 AACR-NCI-EORTC International Conference

PRESENTATION - AACR-NCI-EORTC 2023 - Updated Phase 1 results from the PYNNACLE Phase 1/2 study of PC14586, a selective p53 reactivator, in patients with advanced solid tumors harboring a TP53 Y220C mutation

Upcoming Events

Investor Relations events will be posted soon.

Past Events

Mar 9, 2022 at 9:10 AM EST

Cowen’s 42nd Annual Health Care Conference

Feb 9, 2022 at 10:30 AM EST

Guggenheim Healthcare Talks 2022 Oncology Day

Sep 9, 2021 at 4:15 PM EDT

Morgan Stanley 19th Annual Global Healthcare Conference

Jun 14, 2021 at 2:30 PM EDT

Bank of America Securities 2021 Napa Biopharma Virtual Conference

Jun 9, 2021 at 5:30 PM EDT

Goldman Sachs Annual Global Healthcare Conference

May 13, 2021 at 12:30 PM EDT

Bank of America Healthcare Conference

Pagination

First page
Previous page
Page 1
Current page 2

Site - Investor Tools

Print
Email Alerts
RSS Feeds
Contact IR
Email Page

Overview
Press Releases
Events & Presentations
Financials & Filings
- SEC Filings
- Quarterly Results
Corporate Governance
- Governance Overview
- Committee Composition
ESG
Stock Information
Shareholder Services

About
Science
Pipeline
Investors
Life at PMV
- Working at PMV
- Job Opportunities
Contact

Site - Mobile

Home
About
Science
Pipeline
- PMV Pipeline
- PC14586
Investors
Life at PMV
- Working at PMV
- Job Opportunities
Contact
Terms of Use
Privacy Policy

© 2024 PMV Pharmaceuticals, Inc. All rights reserved

Terms of Use
Privacy Policy